CHAPEL HILL, N.C., Aug. 24, 2012 /PRNewswire/ -- New Product Planning is called many things - New Product Commercialization, New Product Development, or just Commercial Planning. While the new product planning function goes by many names, those working in the role are all seeking the same result: successful product commercialization.
Some 3,000 medicines are in development in the United States for roughly 4,000 different indications. Still, the industry is grappling with depleted pipelines, fewer approvals and rising development costs. Understandably, the New Product Planning (NPP) function is under increasing pressure to perform and thus the function has found itself becoming involved earlier and earlier in the development cycle.
A new data-rich benchmarking study from research and consulting firm Best Practices, LLC delivers actionable insights on the critical elements of the new product planning (NPP) function. The study, Driving Growth through Planning, Structure and Activities: Best Practices in Pharmaceutical New Product Planning, identifies the full set of activities that NPP groups perform across the development cycle. Beyond examining the timing and reasons behind critical New Product Planning activities, this 72-page written report delves into how the function's structure and interactions with other functions play a role in its influence.
Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies. The research report reflects the current state of New Product Planning efforts at leading organizations.
Topics covered in this study include:
- NPP Group Structures, Roles and Responsibilities
- Interactions and Optimal Working Relationships between Regional and Global NPP Groups
- Examining the Full Set of Activities NPP Groups Perform, their timing, intended outcomes and value
To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1173.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
|SOURCE Best Practices, LLC|
Copyright©2012 PR Newswire.
All rights reserved